On-demand webinar
Obesity: How Should GLP-1s Fit Into America’s Weight Loss Solution?
Obesity: How Should GLP-1s Fit Into America’s Weight Loss Solution?
About the webinar
America’s struggle with excess weight has brought both fad diets and companies guaranteeing a weight loss silver bullet. The outcomes promised by weight loss medications like GLP-1s have many employers and health plans anxious. Is this yet another fad, and is it possible to control the large price tag?
As with other chronic conditions like diabetes and depression, medications play an important role — at least for some people. What role should medications play in treating obesity?
In this webinar, obesity expert Dr. Fatima Cody Stanford joined Vida’s Chief Medical Officer Dr. Richard Frank to discuss why:
- Obesity needs to be seen as a chronic health condition like diabetes or depression
- An effective management plan for obesity should consider a combination of prescriptions (like GLP-1s) and behavior change
- A combination of human providers and advanced technology are essential to scale clinical and financial outcomes across any population struggling with obesity
Featured speakers
Dr. Richard Frank
Chief Medical Officer
at Vida
Kevin Knight
Chief Marketing Officer
at Vida
Dr. Fatima Cody Stanford MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS
Associate Professor of Medicine at Harvard
Curious to read more?
Obesity is crippling the US, but there are solutions explores how to stop the obesity epidemic in its tracks.